Found: 1
Select item for more details and to access through your institution.
Cost-per-responder analysis of tralokinumab versus dupilumab in patients with moderate-to-severe atopic dermatitis in the US and Canada.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii42, doi. 10.1093/bjd/ljad498.044
- By:
- Publication type:
- Article